Sean Bohen, PRESIDENT AND CEO at Olema Pharmaceuticals, Inc. (OLMA), sold 871 shares at $30.05 ($26K) on 2021-09-01, disclosed to the SEC on 2021-09-03.
Scheduled sale ($26k) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| OLMA | SELL | 2021-10-15 | $294K | — | Filing → |
| OLMA | SELL | 2021-09-29 | $33K | — | Filing → |
| OLMA | SELL | 2021-09-09 | $91K | — | Filing → |